Bovine Mastitis Market

Global Bovine Mastitis Market Size

The global bovine mastitis market was valued at USD 0.82 billion in 2025, is estimated to reach USD 0.88 billion in 2026, and is projected to reach USD 1.54 billion by 2034, growing at a CAGR of 7.28% from 2026 to 2034.

MARKET DRIVERS

The growing demand for dairy products is one of the major factors propelling the growth of the bovine mastitis market. The demand for dairy products like milk, cheese, butter, and whey also has significantly increased with the growing population. India ranked as the largest consumer of cow milk globally, with a consumption of approximately 85 million metric tons in 2022. The European Union followed with the second-highest milk consumption, amounting to 23.8 million metric tons. The demand for milk is estimated to keep on increasing. Bovine mastitis can affect this demand as bovine mastitis affects the milk quality and quantity significantly by reducing the average milk output by 50%.

The growing awareness of bovine mastitis among people further contributes to the global market. In recent years, there has been a noticeable increase in awareness about bovine mastitis among dairy farmers, veterinarians, industry professionals and stakeholders. The adverse impact of mastitis on milk production and quality, as well as the animal welfare implications, have managed to gain attention. During a study, it was found that for 150 cattle dairy farms, 57.1% of cows were affected by mastitis, with 19% of them having clinical mastitis (CM). The annual economic loss related to subclinical mastitis (SCM) was 21,933,258.6 LE. This has led to Farmers and dairy-based companies investing heavily in the Bovine Mastitis Market with constant efforts for R&D. NovaQuest Capital invested $20 million in an Israeli biotech company, Mileutis, for developing products to manage and treat bovine mastitis. The growing investments from governmental and non-governmental organizations in R&D efforts fuel the growth rate of the global market.

MARKET RESTRAINTS

The overuse or misuse of antibiotics for the treatment of bovine mastitis has become a significant concern within the dairy industry and veterinary community and is a major restraint for the global bovine mastitis market. Antibiotics have been a crucial tool in managing mastitis by controlling bacterial infections and reducing inflammation in affected cows. However, the widespread and often inappropriate use of antibiotics has led to bacteria adapting to the antibiotics and becoming more and more resistant. Constant R&D efforts with heavy investments are taking place to generate stronger antibiotics. The overuse of antibiotics also caused the government to intervene and put in regulations for the use of antibiotics and other pharmaceuticals for the treatment of bovine mastitis. Despite the prevalence, a significant population still lacks the basic awareness of bovine mastitis and its causes and effects, which limits the bovine mastitis market growth.

REPORT COVERAGE

SEGMENT ANALYSIS

By Type Insights

Based on type, the clinical mastitis segment is predicted to account for the major share of the global bovine mastitis market during the forecast period. Clinical mastitis is a more common form and has more severe effects than sub-clinical mastitis.

The sub-clinical mastitis segment is expected to hold a considerable share of the worldwide market in the coming years owing to its economic impact and growing awareness.

By Treatment Type Insights

Based on treatment type, the antibiotics segment is predicted to dominate the global bovine mastitis market during the forecast period. Antibiotics are easier to acquire and cost-effective. These factors are majorly driving the growth of the antibiotics segment in the global bovine mastitis market.

The vaccine segment is estimated to gain a considerable share of the worldwide market during the forecast period due to increasing awareness and investments by governments and private entities.

By Route of Administration Insights

The intra-mammary segment is projected to account for the largest share of the global market in the coming years. Intra-mammary means applying the medication directly to the affected part of the udder. Mastitis is a bacterial and direct application of antibacterials that has a fast effect over systemic medications.

On the other hand, the systemic segment is expected to record a promising CAGR during the forecast period. Systemic medications such as painkillers are exhibiting rapid growth.

By End-user Insights

The hospitals and clinics claimed the highest share of the global bovine mastitis market in 2022 and the domination is most likely to continue throughout the forecast period. Cows infected by bovine mastitis are brought into the hospitals and clinics for immediate treatment in the majority of the cases, which is one of the major factors contributing to the segmental growth.

REGIONAL ANALYSIS

The Asia-Pacific region holds the most prominent share of the worldwide market. The Asia-Pacific region has a high demand for dairy products. China has the highest demand and is leading the region, followed closely by India, with prominent dairy industries and high demand. Indonesia has a high growth in the dairy market. These attributes propel the requirement for an effective treatment for bovine mastitis across the Asia-Pacific region, one of the most common diseases in cows.

North America is one of the most promising regional markets in the global bovine mastitis market and is expected to account for the second largest share of the global market during the forecast period due to increasing demand and the presence of large research institutes in the region along with a significant population of dairy cow herds.

Europe is expected to grow at a notable CAGR in the global market in the coming years. Europe has been one of the constant producers of dairy, with a constant demand for milk and dairy-based products. Countries like Italy and France are leading the Regional Market.

Middle East & Africa is estimated to hold a considerable share of the global bovine mastitis market during the forecast period owing to the growing demand for dairy products.

Latin America is predicted to showcase a healthy CAGR in the coming years due to the growing population and increase in the consumption of dairy-based products in the region.

KEY MARKET PLAYERS

Some of the companies that are playing a dominating role in the global bovine mastitis market include

• Ecolab Inc.
• Forte Healthcare Ltd.
• Thermo Fisher Scientific Inc.
• Mileutis Ltd.
• Merck KGaA
• Boehringer Ingelheim GmbH
• Zoetis Inc.
• Neogen Corporation
• Huvepharma NV
• Armenta Ltd.

MARKET SEGMENTATION

This research report on the bovine mastitis market has segmented and sub-segmented based on type, treatment type, route of administration, end-user and region.

By Type

• Clinical Mastitis
• Sub-Clinical Mastitis

By Treatment Type

• Antibiotics
• Surgery
• Vaccines
• Pain Killers and Others

By Route of Administration

• Intra-Mammary
• Systemic

By End-user

• Hospitals and Clinics
• Veterinary Centers
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa